These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17149721)

  • 21. G2019S LRRK2 mutation in familial and sporadic Parkinson's disease in Russia.
    Pchelina SN; Yakimovskii AF; Ivanova ON; Emelianov AK; Zakharchuk AH; Schwarzman AL
    Mov Disord; 2006 Dec; 21(12):2234-6. PubMed ID: 17044089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's disease.
    Li C; Ting Z; Qin X; Ying W; Li B; Guo Qiang L; Jian Fang M; Jing Z; Jian Qing D; Sheng Di C
    Mov Disord; 2007 Dec; 22(16):2439-43. PubMed ID: 17960808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lrrk2 p.Q1111H substitution and Parkinson's disease in Latin America.
    Mata IF; Wilhoite GJ; Yearout D; Bacon JA; Cornejo-Olivas M; Mazzetti P; Marca V; Ortega O; Acosta O; Cosentino C; Torres L; Medina AC; Perez-Pastene C; Díaz-Grez F; Vilariño-Güell C; Venegas P; Miranda M; Trujillo-Godoy O; Layson L; Avello R; Dieguez E; Raggio V; Micheli F; Perandones C; Alvarez V; Segura-Aguilar J; Farrer MJ; Zabetian CP; Ross OA
    Parkinsonism Relat Disord; 2011 Sep; 17(8):629-31. PubMed ID: 21632271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal.
    Ferreira JJ; Guedes LC; Rosa MM; Coelho M; van Doeselaar M; Schweiger D; Di Fonzo A; Oostra BA; Sampaio C; Bonifati V
    Mov Disord; 2007 Jun; 22(8):1194-201. PubMed ID: 17469194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel P755L mutation in LRRK2 gene associated with Parkinson's disease.
    Wu T; Zeng Y; Ding X; Li X; Li W; Dong H; Chen S; Zhang X; Ma G; Yao J; Deng X
    Neuroreport; 2006 Dec; 17(18):1859-62. PubMed ID: 17179858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation.
    Luzón-Toro B; Rubio de la Torre E; Delgado A; Pérez-Tur J; Hilfiker S
    Hum Mol Genet; 2007 Sep; 16(17):2031-9. PubMed ID: 17584768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
    Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial 123metaiodobenzylguanidine uptake in genetic Parkinson's disease.
    Quattrone A; Bagnato A; Annesi G; Novellino F; Morgante L; Savettieri G; Zappia M; Tarantino P; Candiano IC; Annesi F; Civitelli D; Rocca FE; D'Amelio M; Nicoletti G; Morelli M; Petrone A; Loizzo P; Condino F
    Mov Disord; 2008 Jan; 23(1):21-7. PubMed ID: 17975812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel LRRK2 mutation in an Austrian cohort of patients with Parkinson's disease.
    Haubenberger D; Bonelli S; Hotzy C; Leitner P; Lichtner P; Samal D; Katzenschlager R; Djamshidian A; Brücke T; Steffelbauer M; Bancher C; Grossmann J; Ransmayr G; Strom TM; Meitinger T; Gasser T; Auff E; Zimprich A
    Mov Disord; 2007 Aug; 22(11):1640-3. PubMed ID: 17523199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for SNCA and LRRK2 mutations in Greek sporadic and autosomal dominant Parkinson's disease: identification of two novel LRRK2 variants.
    Xiromerisiou G; Hadjigeorgiou GM; Gourbali V; Johnson J; Papakonstantinou I; Papadimitriou A; Singleton AB
    Eur J Neurol; 2007 Jan; 14(1):7-11. PubMed ID: 17222106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
    Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N
    Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of LRRK2 mutations and Parkinson's disease in Brazil.
    Pimentel MM; Moura KC; Abdalla CB; Pereira JS; de Rosso AL; Nicaretta DH; Campos M; de Almeida RM; dos Santos JM; Bastos IC; Mendes MF; Maultasch H; Costa FH; Werneck AL; Santos-Rebouças CB
    Neurosci Lett; 2008 Mar; 433(1):17-21. PubMed ID: 18201824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence.
    Tan EK; Zhao Y; Skipper L; Tan MG; Di Fonzo A; Sun L; Fook-Chong S; Tang S; Chua E; Yuen Y; Tan L; Pavanni R; Wong MC; Kolatkar P; Lu CS; Bonifati V; Liu JJ
    Hum Genet; 2007 Feb; 120(6):857-63. PubMed ID: 17019612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive analysis of LRRK2 in publicly available Parkinson's disease cases and neurologically normal controls.
    Paisán-Ruíz C; Nath P; Washecka N; Gibbs JR; Singleton AB
    Hum Mutat; 2008 Apr; 29(4):485-90. PubMed ID: 18213618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans.
    Lesage S; Janin S; Lohmann E; Leutenegger AL; Leclere L; Viallet F; Pollak P; Durif F; Thobois S; Layet V; Vidailhet M; Agid Y; Dürr A; Brice A; ; Bonnet AM; Borg M; Broussolle E; Damier P; Destée A; Martinez M; Penet C; Rasco O; Tison F; Tranchan C; Vérin M
    Arch Neurol; 2007 Mar; 64(3):425-30. PubMed ID: 17353388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation.
    Giordana MT; D'Agostino C; Albani G; Mauro A; Di Fonzo A; Antonini A; Bonifati V
    Mov Disord; 2007 Jan; 22(2):275-8. PubMed ID: 17149743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease.
    Di Fonzo A; Rohé CF; Ferreira J; Chien HF; Vacca L; Stocchi F; Guedes L; Fabrizio E; Manfredi M; Vanacore N; Goldwurm S; Breedveld G; Sampaio C; Meco G; Barbosa E; Oostra BA; Bonifati V;
    Lancet; 2005 Jan 29-Feb 4; 365(9457):412-5. PubMed ID: 15680456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
    Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
    Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lrrk2 mutations in South America: A study of Chilean Parkinson's disease.
    Perez-Pastene C; Cobb SA; Díaz-Grez F; Hulihan MM; Miranda M; Venegas P; Godoy OT; Kachergus JM; Ross OA; Layson L; Farrer MJ; Segura-Aguilar J
    Neurosci Lett; 2007 Jul; 422(3):193-7. PubMed ID: 17614198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LRRK2: a link between familial and sporadic Parkinson's disease?
    Lesage S; Dürr A; Brice A
    Pathol Biol (Paris); 2007 Mar; 55(2):107-10. PubMed ID: 16884863
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.